| Literature DB >> 35365635 |
Javier Rodríguez-Ubreva1,2, Anna Arutyunyan3,4, Marc Jan Bonder5,6,7, Lucía Del Pino-Molina8, Stephen J Clark9, Carlos de la Calle-Fabregat10,11, Luz Garcia-Alonso3, Louis-François Handfield3, Laura Ciudad10,11, Eduardo Andrés-León12, Felix Krueger13, Francesc Català-Moll10,11, Virginia C Rodríguez-Cortez11, Krzysztof Polanski3, Lira Mamanova3, Stijn van Dongen3, Vladimir Yu Kiselev3, María T Martínez-Saavedra14, Holger Heyn15,16, Javier Martín12, Klaus Warnatz17,18, Eduardo López-Granados8, Carlos Rodríguez-Gallego14,19, Oliver Stegle5,6,7,20, Gavin Kelsey4,9, Roser Vento-Tormo21,22, Esteban Ballestar23,24,25.
Abstract
Common variable immunodeficiency (CVID), the most prevalent symptomatic primary immunodeficiency, displays impaired terminal B-cell differentiation and defective antibody responses. Incomplete genetic penetrance and ample phenotypic expressivity in CVID suggest the participation of additional pathogenic mechanisms. Monozygotic (MZ) twins discordant for CVID are uniquely valuable for studying the contribution of epigenetics to the disease. Here, we generate a single-cell epigenomics and transcriptomics census of naïve-to-memory B cell differentiation in a CVID-discordant MZ twin pair. Our analysis identifies DNA methylation, chromatin accessibility and transcriptional defects in memory B-cells mirroring defective cell-cell communication upon activation. These findings are validated in a cohort of CVID patients and healthy donors. Our findings provide a comprehensive multi-omics map of alterations in naïve-to-memory B-cell transition in CVID and indicate links between the epigenome and immune cell cross-talk. Our resource, publicly available at the Human Cell Atlas, gives insight into future diagnosis and treatments of CVID patients.Entities:
Mesh:
Year: 2022 PMID: 35365635 PMCID: PMC8975885 DOI: 10.1038/s41467-022-29450-x
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694